Aller au contenu principal
Accès ouvert déclaré 2026 article

Persistent Antinuclear Antibodies Positivity Predicts Progression to Systemic Lupus Erythematosus in Paediatric Autoimmune Cytopenias: A Retrospective Cohort Study

0Citations signalées — pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Objective: Autoimmune cytopenias (AIC) may be associated with positive antinuclear antibodies (ANA) and can precede the onset of systemic lupus erythematosus (SLE). This study assessed ANA as a predictive factor for progression to SLE in adolescents with AIC. Methods: Medical records from a paediatric haematology referral centre were retrospectively reviewed. Presence of ANA (titer>1:80) was recorded in 90 adolescents and children with AIC. Possible progression to SLE was evaluated in the group. Results: A total of 90 patients with AIC were included, with a median age of 9 years and a predominance of ITP (67/90). ANA positivity was identified in 35/90 patients with AIC, most frequently in females (25/35). Among ANA-positive patients, 6/35 eventually developed SLE, whereas none of the ANA-negative patients progressed to SLE. Of the patients who developed SLE, the majority were female (5/6), with 5/6 initially diagnosed with autoimmune thrombocytopenia and 1 with Evans syndrome. The median age at AIC onset for those who later developed SLE was 10.4 years, and the median time interval between AIC diagnosis and SLE onset was 2.5 years. Additionally, 10/35 ANA-positive patients met high-risk criteria for future SLE according to Lambers et al. (2020), despite not fulfilling EULAR/ACR-2019 criteria for SLE at the time of review. Conclusions: Persistent ANA positivity in patients with AIC strongly predicts subsequent SLE, particularly in females older than 10 years with ITP. This finding warrants further investigation in larger, prospective studies, including follow-up of patients transitioning to adult care, as SLE may manifest later in adulthood. Cite this article as: Diamantidou V, Tragiannidis A, Trachana M, Galli-Tsinopoulou A, Economou M-K. Persistent Antinuclear Antibodies Positivity Predicts Progression to Systemic Lupus Erythematosus in Paediatric Autoimmune Cytopenias: A Retrospective Cohort Study. Mediterr J Rheumatol 2026;37(2):364-369. Article Submitted: 2 Oct 2025; Revised Form: 14 Dec 2025; Article Accepted: 29 Dec 2025; Available Online: 1 Jun 2026 This work is licensed under a Creative Commons Attribution 4.0 International License. ©2026 The Author(s). https://doi.org/10.31138/mjr.021025.epo

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Persistent Antinuclear Antibodies Positivity Predicts Progression to Systemic Lupus Erythematosus in Paediatric Autoimmune Cytopenias: A Retrospective Cohort Study
Date Crossref
01/06/2026
Éditeur
Convin SA
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Blood disorders and treatmentsSystemic Lupus Erythematosus ResearchPlatelet Disorders and Treatments

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.